Lu S et al.45indicated that overexpression of SOX3 predicts a poor outcome in GBM patients; and, Sa JK et al.46found SOX3 is associated with tumour invasiveness, malignancy and poor prognosis in GBM patients. This evidence concerns the gene SOX3 and glioblastoma.